Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes
Parsa Akbari,Olukayode A. Sosina,Jonas Bovijn,Karl Landheer,Jonas B. Nielsen,Minhee Kim,Senem Aykul,Tanima De,Mary E. Haas,George Hindy,Nan Lin,Ian R. Dinsmore,Jonathan Z. Luo,Stefanie Hectors,Benjamin Geraghty,Mary Germino,Lampros Panagis,Prodromos Parasoglou,Johnathon R. Walls,Gabor Halasz,Gurinder S. Atwal,Giusy Della Gatta,Marcus Jones,Michelle G. LeBlanc,Christopher D. Still,David J. Carey,Alice Giontella,Marju Orho-Melander,Jaime Berumen,Pablo Kuri-Morales,Jesus Alegre-Díaz,Jason M. Torres,Jonathan R. Emberson,Rory Collins,Daniel J. Rader,Brian Zambrowicz,Andrew J. Murphy,Suganthi Balasubramanian,John D. Overton,Jeffrey G. Reid,Alan R. Shuldiner,Michael Cantor,Goncalo R. Abecasis,Manuel A. R. Ferreira,Mark W. Sleeman,Viktoria Gusarova,Judith Altarejos,Charles Harris,Aris N. Economides,Vincent Idone,Katia Karalis,Giusy Della Gatta,Tooraj Mirshahi,George D. Yancopoulos,Olle Melander,Jonathan Marchini,Roberto Tapia-Conyer,Adam E. Locke,Aris Baras,Niek Verweij,Luca A. Lotta,Regeneron Genetics Center,DiscovEHR Collaboration
DOI: https://doi.org/10.1038/s41467-022-32398-7
IF: 16.6
2022-08-23
Nature Communications
Abstract:Body fat distribution is a major, heritable risk factor for cardiometabolic disease, independent of overall adiposity. Using exome-sequencing in 618,375 individuals (including 160,058 non-Europeans) from the UK, Sweden and Mexico, we identify 16 genes associated with fat distribution at exome-wide significance. We show 6-fold larger effect for fat-distribution associated rare coding variants compared with fine-mapped common alleles, enrichment for genes expressed in adipose tissue and causal genes for partial lipodystrophies, and evidence of sex-dimorphism. We describe an association with favorable fat distribution ( p = 1.8 × 10 −09 ), favorable metabolic profile and protection from type 2 diabetes (~28% lower odds; p = 0.004) for heterozygous protein-truncating mutations in INHBE , which encodes a circulating growth factor of the activin family, highly and specifically expressed in hepatocytes. Our results suggest that inhibin βE is a liver-expressed negative regulator of adipose storage whose blockade may be beneficial in fat distribution-associated metabolic disease.
multidisciplinary sciences
What problem does this paper attempt to address?